Hold MDLZ as defensive core; await technical confirmation above $64.74 before any laddered position adds
HOLD MDLZ as defensive core holding. The aggressive analyst's case requires three unconfirmed inflection points (technical breakout, Fed dovish pivot, Oreo narrative repricing) making asymmetric risk/reward unfavorable at current $62 entry with negative MACD. The conservative analyst overstates the case for Underweight given the structural floor intact at 200 SMA ($58.56, held 42+ sessions), TTM EBITDA recovery to $6.08B, 77% FCF dividend coverage, and 6.1% total shareholder yield. The neutral analyst's laddered-add framework is correct in principle but should be deferred until confirmation trigger fires. Prior Sept 15 MDLZ HOLD decision produced +0.9% alpha versus failed Underweight calls (-0.5% return). Do not add into weakness; preserve optionality until price closes above $64.74 on volume ≥10M with MACD histogram positive.
| Position | Action |
|---|---|
| Current positioning | Maintain defensive core; no incremental capital deployment |
| Price approaches $64.50-$64.70 zone (upper Bollinger / failed breakout resistance) | Trim position on rallies |
| Technical confirmation trigger: close >$64.74 on volume ≥10M with MACD histogram positive | Begin laddered adds only after confirmation fires |
| 10Y yield decisively crosses above 3.35% dividend yield | Reassess toward Underweight (relative-yield argument breaks) |
| Price reaches $58.56 (200 SMA structural floor) | Hard structural stop on residual position |
MDLZ is undervalued with a PEG below 1.0, offers a 6.1% total shareholder yield through dividends and buybacks, and has a multi-year structural catalyst in the Oreo 2027 relaunch coinciding with favorable defensive rotation dynamics in a hawkish Fed environment.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 62.27 | bullish |
| 50 SMA | 61.87 | bullish |
| 200 SMA | 58.70 | bullish |
| RSI | 50.57 | neutral |
| MACD Line | -0.01 | neutral |
| MACD Signal | 0.04 | neutral |
| MACD Histogram | -0.05 | bearish |
| Bollinger Middle Band | 62.65 | neutral |
| Bollinger Lower Band | 60.66 | neutral |
| ATR | 1.25 | neutral |
| VWMA | 62.06 | bullish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
EV: +$3.84-$2.70 (from $61.87 to $64.70-$65 range)
MDLZ is a low-momentum, range-bound defensive name trading on narrative rather than catalysts—the bull thesis requires four simultaneous conditions to work, creating a four-conditional bet with symmetric-to-negative risk/reward.
· concedes: The dividend yield of 3.35% is real income for patient holders; The technical setup hasn't broken below $60.66 support yet; The capital return policy is aggressive and has supported the stock historically
→ vs conservative: Hawkish Fed argument is backwards: rising 10-year rates above MDLZ's 3.35% yield signal bonds are less competitive for yield-seeking capital, making predictable cash flows and growing dividends MORE attractive in higher-for-longer regime
→ vs conservative: GLP-1 structural risk narrative is lazy: Oreo has survived Atkins, keto, fat-free 90s, and every dietary fad; confectionery is among last categories cut in household budget compression; GLP-1 users represent tiny fraction of addressable market
→ vs conservative: Oreo 2027 relaunch dismissal is a mistake: $5B revenue brand relaunch with new packaging, formulas, and price architecture is a 2026 setup event, not a 2027 event; narrative repricing happens 12-18 months ahead of catalyst, not when packaging hits shelves
→ vs conservative: Technical 'bearish' reading is wrong: lower Bollinger Band at $60.66 being defended, +6.2% above 200 SMA, 50 SMA holding as support, MACD at -0.05 is momentum exhaustion not bearish conviction, RSI at 50.57 is a pivot not a sell signal
→ vs conservative: Capital return floor completely ignored: $4.9B annual return (6.1% total yield) creates a floor even if multiple compresses 10%; ~$1.5B quarterly buybacks persistently remove shares from market
→ vs conservative: Q3 earnings treated as binary risk when it is asymmetric upside: cocoa pressure fully priced in (stock already range-bound), sentiment only 5.9 (bar is low), in-line print with constructive guidance could trigger 5-8% re-rating
Support: 60.66 · 61.87 · 58.7 | Resistance: 64.63 · 64.7 · 62.65
MDLZ is in a healthy long-term uptrend above the 200 SMA but faces near-term consolidation with MACD histogram negative (-0.05), RSI neutral at 50.57, and price sitting closer to the lower Bollinger Band ($60.66) than the middle. The stock trades just above the 10 EMA ($62.27) and 50 SMA ($61.87), which serve as near-term support levels. The overall rating is HOLD—existing holders should maintain positions while new entries wait for a confirmed bounce off the $61.87-$60.66 support zone or a breakout above $64.63 resistance. Low volatility (ATR 1.25) and tight range action ($61.28-$62.47) suggest waiting for a catalyst, likely quarterly earnings in late October.
Market Capitalization
$79.59 B
Share Price
~$62.05
52-Week High
$66.65
52-Week Low
$51.20
50-Day Average
$61.83
200-Day Average
$59.28
PE Ratio (TTM)
22.84
Forward PE
18.55
PEG Ratio
0.92
Price-to-Book
3.00
EPS (TTM)
$2.73
Forward EPS
$3.36
Dividend Yield
3.35%
Beta
0.40
Revenue (TTM)
$39.675 B
Revenue (FY2025)
$38.537 B
Gross Profit (TTM)
$12.357 B
Operating Income (TTM)
$3.627 B
EBITDA (TTM)
$6.080 B
Net Income (TTM)
$3.516 B
Diluted EPS (TTM)
$2.73
Operating Margin (TTM)
21.98%
Profit Margin (TTM)
8.86%
Return on Equity (TTM)
13.34%
Return on Assets (TTM)
4.12%
Operating Cash Flow (TTM)
~$4.61 B
Free Cash Flow (TTM)
$3.24 B
Capex (TTM)
~$1.33 B
Dividends Paid (FY2025)
$2.49 B
Buybacks (FY2025)
$2.39 B
Total Capital Returned (TTM)
~$4.94 B
Total Assets
$71.49 B
Total Liabilities
$45.60 B
Total Stockholders' Equity
$25.84 B
Cash & Equivalents
$2.13 B
Total Debt
$21.80 B
Net Debt
$19.08 B
Working Capital
-$8.91 B
Current Ratio
0.60
Debt/Equity
0.85x
Goodwill + Intangibles
$43.96 B
Treasury Stock
$31.53 B
Book Value Per Share
$20.80
Net PPE
$11.4 B
Interest Expense
$0.60 B
Revenue CAGR (2021→2025)
~5.2%
Diluted Shares Reduction (2021→2025)
-6.3%
FCF/NI (TTM)
~93%
Interest Coverage
~6.0x
Net Debt/FCF
~5.9x
Strengths
Concerns
Mondelez International is a high-quality, defensive compounder with iconic global brands (Oreo, Cadbury, Toblerone, Milka) generating strong FCF of $3.2B+ annually while returning 80-90% to shareholders. The stock trades at a reasonable forward PE of 18.55x with a PEG ratio below 1 (0.92), suggesting modest undervaluation relative to ~23% implied EPS growth. The 2025 earnings print warrants monitoring as FY2025 net income declined to $2.45B (from $4.62B in FY2024) due to a COGS step-up from $22.18B to $27.60B — likely commodity inflation or reclassification — but TTM EBITDA of $6.08B vs. FY2025 EBITDA of $4.97B signals recovery. The balance sheet remains strong with conservative 0.85x Debt/Equity and ~6.0x interest coverage, though negative working capital (-$8.91B) requires ongoing monitoring. With a 3.35% dividend yield, low 0.40 beta, and ~$4.9B annual capital return, MDLZ is best suited for income-oriented long-term holders seeking defensive, low-volatility exposure — short-term traders may want to wait for pullbacks toward the 200-day MA (~$59.28) for better risk/reward.
Macro: The Fed delivered a hawkish surprise on September 16, 2026, hiking rates (not cutting) and sending the Dow down 600 points with S&P 500 and Nasdaq also falling. Bond yields rose sharply. Jamie Dimon (JPM) reinforced the hawkish narrative, stating 'It's not clear to me we've slayed inflation.' Polymarket-implied probabilities show 95% probability of no Fed rate cuts in 2026 (+1.9pp week-over-week), 0% for 12+ cuts, and US recession probability at 12% (+4.0pp week-over-week) — markets are beginning to price 'policy mistake' risk. Sugar prices are softening on weak demand (positive for confectionery COGS). Crypto/CLARITY Act failed in Senate (risk-off indicator, not directly material to MDLZ).